Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation

• Publication date

  2010-08-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.110.952481PMID 20697027PMCID PMC2927811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-Hydroxydecanoate and coenzyme A are inhibitors of native sarcolemmal KATP channels in inside-out patches.

  2010cited by this paper
• Why do we still not have cardioprotective drugs?

  2009cited by this paper
• Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2.

  2009cited by this paper
• Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

  2009cited by this paper
• Getting to the heart of proteomics.

  2009cited by this paper
• Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory Cytokines

  2008cited by this paper
• Recent improvements in the development of A2B adenosine receptor agonists

  2008cited by this paper
• Adenosine: trigger and mediator of cardioprotection

  2008cited by this paper
• Critical review of prorenin and (pro)renin receptor research.

  2008cited by this paper
• Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

  2008cited by this paper
• Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart

  2008cited by this paper
• Signaling pathways in ischemic preconditioning

  2007cited by this paper
• The myocardial no-reflow phenomenon: role of deltaPKC.

  2007cited by this paper
• The myocardial no-reflow phenomenon: Role of δPKC

  2007cited by this paper
• Enhanced mast cell activation in mice deficient in the A2b adenosine receptor

  2007cited by this paper
• Renin: at the heart of the mast cell

  2007cited by this paper
• Adenosinergic cardioprotection: multiple receptors, multiple pathways.

  2007cited by this paper
• Mitochondrial PKC&egr; and Mitochondrial ATP-Sensitive K+ Channel Copurify and Coreconstitute to Form a Functioning Signaling Module in Proteoliposomes

  2006cited by this paper
• Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.

  2006cited by this paper
• Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.

  2006cited by this paper
• Histamine H3-Receptor-Induced Attenuation of Norepinephrine Exocytosis: A Decreased Protein Kinase A Activity Mediates a Reduction in Intracellular Calcium

  2005cited by this paper
• Cardioprotection by &egr;-Protein Kinase C Activation From Ischemia: Continuous Delivery and Antiarrhythmic Effect of an &egr;-Protein Kinase C-Activating Peptide

  2005cited by this paper
• Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.

  2005cited by this paper
• Acetaldehyde Induces Histamine Release from Human Airway Mast Cells to Cause Bronchoconstriction

  2004cited by this paper
• Mast cells: a unique source of renin.

  2004cited by this paper
• Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.

  2003cited by this paper
• Mast Cell–Mediated Stimulation of Angiogenesis: Cooperative Interaction Between A2B and A3 Adenosine Receptors

  2003cited by this paper
• Additive Protection of the Ischemic Heart Ex Vivo by Combined Treatment With &dgr;-Protein Kinase C Inhibitor and &egr;-Protein Kinase C Activator

  2003cited by this paper
• Adenosine Receptor Subtypes Mediating Coronary Vasodilation in Rat Hearts

  2003cited by this paper
• Functional characterization of an endogenous Xenopus oocyte adenosine receptor

  2002cited by this paper
• Acetylcholine, Bradykinin, Opioids, and Phenylephrine, but not Adenosine, Trigger Preconditioning by Generating Free Radicals and Opening Mitochondrial KATP Channels

  2001cited by this paper
• Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure

  2001cited by this paper
• Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.

  2000cited by this paper
• ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology.

  2000cited by this paper
• Protein Kinase C- ξ is Responsible for the Protection of Preconditioning in Rabbit Cardiomyocytes

  1999cited by this paper
• The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

  1999cited by this paper
• Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart.

  1999cited by this paper
• Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges.

  1999cited by this paper
• Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes.

  1999cited by this paper
• Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart.

  1999cited by this paper
• Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation.

  1999cited by this paper
• Sustained in vivo cardiac protection by a rationally designed peptide that causes ɛ protein kinase C translocation

  1999cited by this paper
• Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

  1998cited by this paper
• Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation.

  1997cited by this paper
• Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts.

  1997cited by this paper
• Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.

  1997cited by this paper
• Ischemic Preconditioning Prevents the Impairment of Hypoxic Coronary Vasodilatation Caused by Ischemia/Reperfusion: Role of Adenosine A1/A3 and Bradykinin B2 Receptor Activation

  1997cited by this paper
• Adenosine A2B receptors.

  1997cited by this paper
• Selective Blockade of AT1Angiotensin II Receptors Abolishes Ischemic Preconditioning in Isolated Rabbit Hearts

  1997cited by this paper
• A Protein Kinase C Translocation Inhibitor as an Isozyme-selective Antagonist of Cardiac Function*

  1996cited by this paper
• Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.

  1996cited by this paper
• Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts.

  1995cited by this paper
• Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

  1994cited by this paper
• Nomenclature and classification of purinoceptors.

  1994cited by this paper
• The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.

  1993cited by this paper
• Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography.

  1993cited by this paper
• Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells.

  1993cited by this paper
• In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.

  1992cited by this paper
• Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.

  1992cited by this paper
• Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

  1991cited by this paper
• The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.

  1988cited by this paper
• Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

  1986cited by this paper
• Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells.

  1979cited by this paper

• Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system

  2025cites this paper
• Effects of 8-week ischemic preconditioning on swimming performance and power output in male 100-m freestyle swimmers: a randomized controlled trial

  2025cites this paper
• ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation.

  2024cites this paper
• Pharmacological activation of aldehyde dehydrogenase 2 inhibits ferroptosis via SLC7A11/GPX4 axis to reduce kidney stone formation.

  2024cites this paper
• Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition

  2024cites this paper
• Adenosine A3 Receptor: From Molecular Signaling to Therapeutic Strategies for Heart Diseases

  2024cites this paper
• The role of aldehyde dehydrogenase 2 in cardiovascular disease

  2023cites this paper
• Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3β-mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy

  2023cites this paper
• Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence

  2023cites this paper
• Aldehyde dehydrogenase 2 and arrhythmogenesis.

  2022cites this paper
• LJ529 attenuates mast cell-related inflammation via A3R-PKCε-ALDH2 pathway after subarachnoid hemorrhage in rats.

  2021cites this paper
• Diabetic Aldehyde Dehydrogenase 2 Mutant (ALDH2*2) Mice Are More Susceptible to Cardiac Ischemic‐Reperfusion Injury Due to 4‐Hydroxy‐2‐Nonenal Induced Coronary Endothelial Cell Damage

  2021cites this paper
• E-cigarette aerosol exacerbates cardiovascular oxidative stress in mice with an inactive aldehyde dehydrogenase 2 enzyme

  2021cites this paper
• Risk of incident atrial fibrillation with low-to-moderate alcohol consumption is associated with gender, region, alcohol category: a systematic review and meta-analysis.

  2021cites this paper
• A Retinoic Acid β2‐Receptor Agonist Exerts Cardioprotective Effects

  2021cites this paper
• ALDH2 deficiency induces atrial fibrillation through dysregulated cardiac sodium channel and mitochondrial bioenergetics: a multi-omics analysis.

  2021cites this paper
• Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD

  2020cites this paper
• Precision Medicine Considerations for the Management of Heart Disease and Stroke in East Asians

  2020influential citation
• Aldh2 Attenuates Stem Cell Factor/Kit-Dependent Signaling and Activation in Mast Cells

  2019cites this paper
• Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy

  2019cites this paper
• ALDH2 and Cardiovascular Disease.

  2019cites this paper
• Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019

  2019cites this paper
• A Review of Humoral Factors in Remote Preconditioning of the Heart

  2019cites this paper
• Regulation of Type 2 Immunity in Myocardial Infarction

  2019cites this paper
• Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

  2019cites this paper
• Mast cell tryptase - Marker and maker of cardiovascular diseases.

  2019cites this paper
• Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis.

  2019cites this paper
• Alda-1, an aldehyde dehydrogenase-2 agonist, improves long-term survival in rats with chronic heart failure following myocardial infarction

  2018cites this paper
• A Retinoic Acid β2-Receptor Agonist Exerts Cardioprotective Effects

  2018cites this paper
• The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease

  2018cites this paper
• ALDH2 protects against alcoholic cardiomyopathy through a mechanism involving the p38 MAPK/CREB pathway and local renin-angiotensin system inhibition in cardiomyocytes.

  2018cites this paper
• Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes

  2018cites this paper
• Cardioprotection induced by a brief exposure to acetaldehyde: role of aldehyde dehydrogenase 2

  2018cites this paper
• Adenosine Receptors: Structure, Distribution, and Signal Transduction

  2018cites this paper
• Mast cell disorders: From infancy to maturity

  2018cites this paper
• Degranulation of gastrointestinal mast cells contributes to hepatic ischemia–reperfusion injury in mice

  2018cites this paper
• [Activation of aldehyde dehydrogenase 2 alleviates H 2O 2-induced injury in cardiomyocytes].

  2018cites this paper
• S1P receptor 1-Mediated Anti–Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2

  2017influential citation
• Complex inhibition of autophagy by mitochondrial aldehyde dehydrogenase shortens lifespan and exacerbates cardiac aging.

  2017cites this paper
• Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia

  2017cites this paper
• Inhibition of ALDH2 expression aggravates renal injury in a rat sepsis syndrome model.

  2017cites this paper
• Increased expression of microRNA-378a-5p in acute ethanol exposure of rat cardiomyocytes

  2017cites this paper
• Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?

  2016cites this paper
• Cardiovascular symptoms in patients with systemic mast cell activation disease.

  2016cites this paper
• Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.

  2016cites this paper
• Mast Cell: A Multi-Functional Master Cell

  2016cites this paper
• Mast Cells Play an Important Role in the Pathogenesis of Hyperglycemia‐Induced Atrial Fibrillation

  2016cites this paper
• The impact of mast cells on cardiovascular diseases.

  2016cites this paper
• Regulation of the Cardiovascular System by Histamine.

  2016cites this paper
• Mitochondrial aldehyde dehydrogenase activity protects against lipopolysaccharide‑induced cardiac dysfunction in rats.

  2015cites this paper
• Mitochondrial aldehyde dehydrogenase in myocardial ischemia-reperfusion injury: from bench to bedside.

  2015cites this paper
• PROTEIINIKINAASI C:N ESTÄJIEN KEHITTÄMINEN ILMAISTEN TIETOKONEAVUSTEISTEN MENETELMIEN AVULLA

  2015cites this paper
• ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress.

  2015cites this paper
• Involvement of nitric oxide and reactive oxygen species in the early anddelayed antiarrhythmic effects of preconditioning

  2015cites this paper
• ALDH 2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress

  2015cites this paper
• A Role for Mast Cells in Alcohol-Induced Tissue Damage and Remodeling

  2015cites this paper
• Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia: Potential Impact on the Development of Coronary Collateral Circulation.

  2015cites this paper
• Molecular pathways of arterial aging.

  2015cites this paper
• The A3 Adenosine Receptor: History and Perspectives

  2015cites this paper
• E‐NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role

  2015cites this paper
• A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy.

  2015cites this paper
• Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress

  2015cites this paper
• Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury.

  2014cites this paper
• IgE receptor-mediated mast-cell renin release.

  2014cites this paper
• Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain

  2014cites this paper
• The role of mast cells in ischemia and reperfusion injury

  2014cites this paper
• Hydrogen Sulfide Prevents Heart Failure Development via Inhibition of Renin Release from Mast Cells in Isoproterenol-Treated Rats

  2014cites this paper
• Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

  2014cites this paper
• Bryostatin-1 Restores Hippocampal Synapses, Learning, and Memory in Fragile X Mice

  2014influential citation
• Sex Differences in Inflammation During Atherosclerosis

  2014cites this paper
• Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease

  2014cites this paper
• Mitochondrial Aldehyde Dehydrogenase (ALDH2) Accentuates Aging-Induced Cardiac Remodeling and Contractile Dysfunction: Role of AMPK, Sirt1 and Mitochondrial Function

  2014cites this paper
• Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.

  2014cites this paper
• Histamine H4-Receptors Inhibit Mast Cell Renin Release in Ischemia/Reperfusion via Protein Kinase Cε-Dependent Aldehyde Dehydrogenase Type-2 Activation

  2014influential citation
• Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection.

  2013influential citation
• A non-cardiomyocyte autonomous mechanism of cardioprotection involving the SLO1 BK channel

  2013cites this paper
• Investigating Organic Nitrate Tolerance and Alzheimer's Disease: Roles for Aldehyde Dehydrogenase 2 and 4-Hydroxynonenal

  2013cites this paper
• ALDH2, a novel protector against stroke?

  2013cites this paper
• Activation of ALDH2 with ethanol attenuates diabetes induced myocardial injury in rats.

  2013cites this paper
• Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor gamma

  2013cites this paper
• Mechanisms of Cardiovascular Aging

  2013cites this paper
• The cellular autophagy markers Beclin-1 and LC3B-II are increased during reperfusion in fibrillated mouse hearts.

  2013cites this paper
• mTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism

  2012cites this paper
• Histamine 3 Receptor Activation Reduces the Expression of Neuronal Angiotensin II Type 1 Receptors in the Heart

  2012cites this paper
• Aldehyde Dehydrogenase Type 2 Activation by Adenosine and Histamine Inhibits Ischemic Norepinephrine Release in Cardiac Sympathetic Neurons: Mediation by Protein Kinase Cε

  2012influential citation
• Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function

  2012cites this paper
• Frontiers in Research: Obesity and Health Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart

  2012cites this paper
• Adenosine receptors in health and disease.

  2011cites this paper
• Bronchial epithelial cells release IL-6, CXCL1 and CXCL8 upon mast cell interaction.

  2011cites this paper
• Mast Cell Proteases and Inflammation.

  2011cites this paper
• Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

  2011cites this paper
• Protective effects of apricot kernel oil on myocardium against ischemia-reperfusion injury in rats.

  2011cites this paper
• Taken to heart

  2011cites this paper
• ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.

  2011cites this paper
• Adenosine receptor targeting in health and disease

  2011cites this paper
• Elastokines et Lactosylcéramide : cardioprotection et vieillissement

  2011cites this paper
• AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol.

  2011cites this paper
• A master of versatility to the heart's rescue: mast cells and ischemic preconditioning.

  2010cites this paper
• Interaction between Sensory C-fibers and Cardiac Mast Cells in Ischemia/Reperfusion: Activation of a Local Renin-Angiotensin System Culminating in Severe Arrhythmic Dysfunction

  2010cites this paper